Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.0%

99 terminated/withdrawn out of 1963 trials

Success Rate

91.3%

+4.8% vs industry average

Late-Stage Pipeline

6%

121 trials in Phase 3/4

Results Transparency

0%

3 of 1043 completed trials have results

Key Signals

311 recruiting3 with results58 terminated41 withdrawn

Enrollment Performance

Analytics

N/A
804(78.4%)
Phase 3
88(8.6%)
Phase 2
75(7.3%)
Phase 4
33(3.2%)
Phase 1
25(2.4%)
Early Phase 1
1(0.1%)
1026Total
N/A(804)
Phase 3(88)
Phase 2(75)
Phase 4(33)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1963)

Showing 20 of 1963 trials
NCT06858761Not ApplicableRecruiting

Health-economic Assessment of Robot-assisted Bariatric Surgery

Role: lead

NCT07295457Not ApplicableRecruiting

Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)

Role: lead

NCT06245434Not ApplicableRecruiting

Circadian Rhythmicity During Coma Awakening

Role: lead

NCT07737639Completed

Evaluating Facial Skin Quality Changes Post-Lipofilling

Role: collaborator

NCT07273019Not ApplicableRecruiting

Tongue Muscular Assessment in Children With Sleep Disordered Breathing

Role: lead

NCT07734363Recruiting

Role of Craving in the Transition Across Level of Addiction Severity: A Longitudinal Study.

Role: collaborator

NCT06834633Not ApplicableRecruiting

Nephroprotection in Severe Trauma Patients With Kidney Stress

Role: lead

NCT06469463Not ApplicableCompleted

Decoding Motor Imagery From Non-invasive Brain Recordings as a Prerequisite for Innovative Motor Rehabilitation Therapies

Role: lead

NCT06801184Recruiting

Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production

Role: lead

NCT06251713Not ApplicableRecruiting

Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery

Role: lead

NCT07723560Recruiting

Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)

Role: lead

NCT06921720Not ApplicableRecruiting

Phosphorus-31 Spectroscopy in Phosphate Diabetes

Role: lead

NCT07721350Not ApplicableNot Yet Recruiting

Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System

Role: lead

NCT07717047Not ApplicableNot Yet Recruiting

STETHO'TOP Study: Evaluation of the Impact of Potential Optimization Techniques on General Self-Efficacy Among Nursing Students Throughout Their Educational Curriculum

Role: lead

NCT03225365Not ApplicableCompleted

Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma

Role: lead

NCT07698093Not Yet Recruiting

Monitoring of Septic Shock-induced Immunosuppression

Role: lead

NCT04067674Recruiting

Septic Shock-induced Immunosuppression

Role: lead

NCT07569120Not ApplicableRecruiting

In Vivo Noradrenergic System and Aging

Role: lead

NCT06306014Phase 1Recruiting

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients

Role: lead

NCT06552234Phase 2Recruiting

Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC

Role: collaborator